FDA Clears Rapid PCR System for Rapid Respiratory Virus Testing
The system simultaneously detects RSV, influenza A and B, and SARS-CoV-2 from a nasal swab in under 10 minutes.
The system simultaneously detects RSV, influenza A and B, and SARS-CoV-2 from a nasal swab in under 10 minutes.
The company aims to support FDA 510(k) clearance submission for its point-of-care platform detecting flu A/B, COVID-19, and RSV.
QIAGEN's QIAstat-Dx Respiratory Panel Mini provides fast and accurate diagnosis of upper respiratory infections in outpatient settings.
Researchers have developed an advanced electrostatic air sampler that enhances rapid detection of airborne influenza and coronavirus.
Read MoreQIAGEN’s QIAstat-Dx Respiratory Panel Plus, a syndromic testing tool for diagnosing respiratory infections, received FDA clearance.
Read MoreADLM’s new guidance on clinical testing for respiratory viral infections emphasizes the use of advanced diagnostic methods and sample types.
Read MoreResearchers demonstrated that metal-enhanced fluorescence probes could rapidly detect influenza virus proteins without complex lab equipment.
Read MoreEvidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Read MoreA parallel test developed by Karius aims to improve treatment for serious diseases by diagnosing infections more rapidly and effectively.
Read MoreThe new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
Read MoreNew data provides a unique snapshot of the interplay among SARS-CoV-2, influenza, and respiratory syncytial virus (RSV).
Read MoreSAS and the Texas DSHS are teaming up on new public health dashboards powered by SAS Viya for tracking influenza data across the state.
Read MoreSekisui Diagnostics’ OSOM Ultra Plus Flu A&B Test is a rapid antigen test that takes only 10 minutes at the point of care.
Read MoreHologic Inc. announced that the FDA has granted 510(k) clearance for the company’s Panther Fusion SARS-CoV-2/Flu A/B/RSV assay.
Read MoreCue Health announced that it has made a De Novo submission to the FDA for full clearance of the Cue RSV Molecular Test.
Read MoreScientists report using a nanomaterials-based sensor that can detect the presence of the viruses that cause COVID-19 and the flu.
Read MoreBD received Emergency Use Authorization from the US FDA for a new molecular diagnostic combination test for respiratory viruses.
Read MoreNomi Health is expanding its testing offerings to include influenzas A and B at its Utah COVID-19 testing sites.
Read More